To Study The Effect Of 0.01% Atropine Eye, Drop In Prevention Of Myopia Progression In Different Age Group Of Children
Introduction: Low-concentration atropine is an emerging therapy for myopia progression, but its efficacy and optimal concentration remain uncertain. Based on available evidence, 0.01% atropine eye drops are widely used for myopia control, with good efficacy and few side effect. Hence the present study was conducted to assess the effectiveness of 0.01% atropine eye drop in prevention of myopia progression in different age group of children. Materials and Methodology: In this study, 190 participants were included who had been diagnosed with myopia in our hospital at the Department of Ophthalmology. The various inclusion criteria that were followed in this study included those children aged 6 – 12 years of both the genders, diagnosed with myopia of ≤3.0 D, near visual acuity of ≤2.0 D in both the eye. Results: Initially, SE and AL were not significant between the groups. But after evaluating the same after 6 – months, SE in control group showed (-0.60 ± 0.31) and in atropine group (-1.92 ± 0.89) which proved statistically significant changes. The relative reduction in myopia progression throughout the study was observed at around 57%. Conclusion: Low concentration atropine eye drops might be a novel choice that can be used in clinical practice in order to reduce the retard myopia.
- 2022-11-14 (2)
- 2022-11-14 (1)